Skip Navigation

Faculty Directory

Marlene R. Miller, MD

Director of Quality and Safety Initiatives, Johns Hopkins Children's Center

Professor

Departmental Affiliation(s):

School of Medicine (Primary)
Health Policy and Management (Joint)

Contact Information

CMSC 2-125
600 N. Wolfe Street
Baltimore , Maryland
US        

443-287-5365
410-955-0761

SciVal Experts Research Profile

Education

MD
MS

Overview

qualtiy and safety of healthcare particularly as it relates to children and involving the full spectrum from measurement to quality and safety interventions

Honors and Awards

Department of Health and Human Service’s Agency for Healthcare Research and Quality’s Article-of-the-Year Award for “Excess length of stay, charges, and mortality attributable to medical errors during hospitalization: an administrative data-based analysis” by Zhan C, Miller MR in JAMA 2003;290:1868-1874 (2004); Department of Health and Human Services Director’s Citation for Outstanding Group Performance on the National Healthcare Disparities Report Data Workgroup (2003); Department of Health and Human Services Secretary’s Award for Distinguished Service as member of AHRQ-MEPS Steering Committee (2002); Agency for Healthcare Research and Quality’s Director’s Award for Merit given for the development of a rigorous and fair process for intramural research review for the emerging intramural research centers (2001); Agency for Healthcare Research and Quality's Director’s Citation for outstanding Group Performance for cross-center teamwork resulting in the drafting and funding of the TRIP II RFA and the creation of and participation on the AHRQ TRIP Internal Coordinating Council (2001)

  • safety
  • quality of care
  • children
  • 1. Walsh KE, Miller, MR, Vinci RJ, Bauchner H. Resident education about medical errors: too little too late. Ambulatory Pediatrics 2004;4(6)514-7 2. Zhan C, Correa-de-Araujo R, Bierman A, Sangl J, Miller M, Wickizer S, Stryer D. Suboptimal prescribing in elderly outpatients: potentially harmful drug-drug and drug-disease combinations. In Press for Journal of the American Geriatric Society 3. Miller MR, Zhan C. Pediatric patient safety in hospitals: a national picture in 2000. Pediatrics 2004;113:1741-6 4. Pronovost P, Nolan T, Zeger S, Miller MR, Rubin H. How can clinicians measure safety and quality in acute care? Lancet 2004;363:1061-67 5. Zhan C, Miller MR, Wong H, Meyer G. The effects of HMO penetration on preventable hospitalizations. Health Services Research 2004;39(2):345-61 6. Miller MR, Pronovost P, Burstin H. Pediatric patient safety in the ambulatory setting. Ambulatory Pediatrics 2004;4(1):47-54 7. Zhan C, Miller MR. Excess length of stay, charges, and mortality attributable to medical errors during hospitalization: an administrative data-based analysis. JAMA 2003;290:1868-1874 8. Zhan C, Miller MR. Administrative data-based patient safety research: a critical review. Quality and Safety in Health Care 2003;12(suppl 2):ii58-63 9. Romano PS, Geppert JJ, Davies S, Miller MR, Elixhauser A, Jiang HJ, McDonald KM. A national profile of patient safety in U.S. hospitals. Health Affairs March/April 2003;22(2):154-166 10. Miller MR, Elixhauser A, Zhan C. Patient Safety Events during Pediatric Hospitalizations. Pediatrics 2003;111:1358-1366 11. Forrest CB, Shipman S, Dougherty D, Miller MR. Outcomes research in pediatric settings: recent trends and future directions. Pediatrics 2003; 111:171-178. 12. Romano PS, Elixhauser A, Miller MR, McDonald K Monitoring patient safety: HIM’s role. Journal of AHIMA 2002;73(3):72-74 13. Zhan C, Sangl J, Bierman A, Miller MR, Wickizer S, Meyer G. Inappropriate drug prescribing for community dwellinng elderly: findings from the 1996 MEPS. JAMA 2001;286(22):2823-2829. 14. Miller MR, Elixhauser A, Zhan C. Patient safety indicators: using administrative data to identify potential patient safety concerns. Health Services Research 2001;36(6) Part II: 110-132 or http://hsr.org/AliceHersh/07-Miller.pdf. 15. Pronovost PJ, Miller MR, Dorman T, Berenholtz SM, Rubin H. Developing and implementing measures of quality of care in the intensive care unit. Curr Opin Crit Care 2001; 7:297-303 16. Segal JB, McNamara RL, Miller MR, Powe NR, Goodman SN, Robinson KA, Bass EB. Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter. (Cochrane Reviews). Cochrane Database Syst Rev. 2001;(1):CD001938. 17. Palmer RH, Miller MR. Methodological challenges in developing and implementing measures of quality for child healthcare. Ambulatory Pediatrics 2001;1:39-52 18. Pronovost PJ, Angus DC, Miller MR. Design considerations in clinical trials on acutely ill patients. Research Practitioner 2000;1:47-54 19. Miller MR, Kan JS, Forrest CB. Parental preferences for primary and specialty care collaboration in the management of teenagers with congenital heart disease. Pediatrics 2000;106:264-269 20. Miller MR, McNamara RL, Segal JB, Kim N, Robinson K, Goodman SN, Powe NR, Bass EB for the Johns Hopkins Evidence-based Practice Center. Efficacy of agents for pharmacological conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials. The Journal of Family Practice 2000;49:1033-1046